Alpha Tau Medical Ltd.DRTSNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank20
3Y CAGR-64.8%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-64.8%/yr
Annual compound
Percentile
P20
Within normal range
vs 3Y Ago
0x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | 2.26% |
| 2023 | 26.49% |
| 2022 | 82.49% |
| 2021 | 51.74% |
| 2020 | 13.68% |
| 2019 | 0.00% |